No adverse events have yet been reported from the defective products, which could cause inflammation at the injection site, artery blockage, and cardiac arrest, among other negative health consequences. Jonathan Perkins Injury Lawyers urges any patients who believe they may have been exposed to these products to visit their healthcare provider.
According to information published by the U.S. Food and Drug Administration (FDA), Baxter customers discovered traces of particulates in the affected products, prompting two lots of Clinimax and one lot of Clinimax E to be recalled. The affected lots were distributed between May 2012 and October 2013 with product codes 2B7729, lot P287045; 2B7717, lot P27588; and 2B7709 lot P285122. Customers were notified and may return the defective products for credit with Baxter.
Parenteral nutritionals are manufactured for use in patients with cancer, hemophilia, kidney disease, immune disorders and a number of other medical conditions as a nutritional supplement with a high caloric content. If any consumers experience side effects such as local irritation at the site of injection, allergic reactions or inflammation of tissue and organs, they have been advised to contact their healthcare provider immediately to discover whether the parenteral nutrition products came from the defective lots.
About Jonathan Perkins Injury Lawyers
Jonathan Perkins Injury Lawyers is committed to helping all those who have been injured by the actions or negligence of another person or entity. The personal injury law firm based in Connecticut handles all types of personal injury claims including auto accident injuries, dangerous drug litigation, medical malpractice, product liability claims, premises liability and wrongful death. For more information and a free, confidential case evaluation, contact us by visiting 800perkins.com or by calling 1-800-PERKINS.
Jonathan Perkins Injury Lawyers
1-800-PERKINS
30 Lucy Street
Woodbridge, CT 06525
Jonathan Perkins Injury Lawyers
PMP Marketing Group
561-253-6712
pressrelease@pmpmg.com
Source: EmailWire.Com
